Fitzpatrick Edward J. 4

4 · Genpact LTD · Filed Aug 12, 2021

Form 4

Period: 2021-08-10

Chief Financial Officer

Transactions

Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-08-10−8,589→ 241,411 total
Exercise: $18.05Exp: 2024-07-14→ Common Shares (8,589 underlying)
Exercise/Conversion
Common Shares
2021-08-10$18.05/sh+8,589$155,031→ 151,207 total
Sale
Common Shares
2021-08-10$51.07/sh−8,589$438,657→ 142,618 total
Exercise/Conversion
Common Shares
2021-08-11$18.05/sh+116,411$2,101,219→ 259,029 total
Sale
Common Shares
2021-08-11$51.03/sh−116,411$5,940,302→ 142,618 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-08-11−116,411→ 125,000 total
Exercise: $18.05Exp: 2024-07-14→ Common Shares (116,411 underlying)

Footnotes (4)

[F1]Includes 26 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 9, 2021. The reporting person currently holds a total of 7,503 shares under the ESPP.
[F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $51.05 to $51.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $50.56 to $51.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F4]The option vested 50% on July 15, 2017 and 50% on July 15, 2019.

Documents

1 file